Safety, tolerability and pharmacokinetics of bolus injection followed by continuous infusion of nicorandil (Sigmart®) in healthy subjects - Phase I study

Authors
Category Primary study
JournalJapanese Pharmacology and Therapeutics
Year 2008
This article has no abstract
Epistemonikos ID: d0d3c7fd45e76aaa261d6dd35d34b6a7ef6c9fd5
First added on: Feb 04, 2025